🔎 Trials Near Me

Akèy › Timè nan sèvo › Texas › San Antonio

Etid klinik pou Timè nan sèvo nan San Antonio, TX

7 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Ap rekriteFaz 2
  • Mays Cancer Center, UT Health San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07470606

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • START San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • UT Health San Antonio Mays Cancer Center, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Ap rekriteEtid obsèvasyon
  • University of Texas Health Science Center of San Antonio, San Antonio
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

Ap rekriteFaz 1/2
  • NEXT Oncology, San Antonio
Laj 18 a 89 · Tout sèks · Mizajou Aug 19, 2025 · NCT06907043

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Ap rekriteFaz 1
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2025 · NCT05460507

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Ap rekriteFaz 1/2
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Etid Timè nan sèvo nan lòt vil

Lòt etid nan San Antonio

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.